Dr. Lucky Tran Jul 23, 2024

A new drug described as “the closest we have ever been to an HIV vaccine” could be sold for $40 a year and still make 30% profit, but is currently being sold by pharma companies for $42,250. Absolutely criminal.

https://www.theguardian.com/global-development/article/2024/jul/23/hiv-aids-prevention-vaccine-lenacapavir-sunlenca-pharmaceuticals-gilead-generic-licensing

HIV drug could be made for just $40 a year for every patient

Generic version of a drug already on the market, which can suppress and prevent HIV, would still yield 30% profit if the current price was slashed, researchers say

The Guardian
Show threadRachel Lawson
@luckytran $40 is a profitable price for a generic version, that’s basically just manufacturing and distribution costs.
What about the cost of development? Not just of this drug but all the ones that didn’t make it through attrition?
Where does the developer recoup development costs?
Jul 24, 2024 at 8:30amWeb